Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in parents treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: Retrospective analysis of 228 cancer patients

American Journal of Hematology

Volumn 81, Issue 1, 2006, Pages 1-4

  Magagnoli, Massimo ^a   Masci, Giovanna ^a   Castagna, Luca ^a   Pedicini, Vittorio ^a   Poretti, Dario ^a   Morenghi, Emanuela ^a   Brambilla, Giorgio ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Catheter; Chemotherapy; Transplant; Warfarin

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; MELPHALAN; THIOTEPA; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BONE MARROW APLASIA; CANCER; CANCER CHEMOTHERAPY; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; INDWELLING CATHETER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SAPHENOUS VEIN; THROMBOCYTE COUNT; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CATHETERIZATION, CENTRAL VENOUS; CYTARABINE; FEMALE; HEMORRHAGE; HUMANS; MALE; MELPHALAN; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET COUNT; PODOPHYLLOTOXIN; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; VENOUS THROMBOSIS; WARFARIN;

EID: 30444457926     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20512     Document Type: Article

References (18)

1. Keung YK, Watkins K, Chen SC, Groshen S, Levine AM, Douer D. Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 1995;18:469-474.
2. Uderzo C, D'Angelo P, Rizzari C, et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 1992;17:87-89.
3. Morrison VA, Peterson BA, Bloomfield CD. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 1990;18:209-216.
4. Ross A, Griffith C, Anderson J. Thromboembolic complications with silicone elastomer subclavian catheters. JPEN J Parenteral Enteral Nutr 1987;6:61-63.
5. rd, May DJ, Alexander HR, et al. Venographic surveillance of tunneled venous access device in adult oncology patients. Ann Surg Oncol 1995;2:174-178.
6. Haire WD, Lieberman RP, Edney J, et al. Hickman catheter-induced thoracic vein thrombosis: frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990;66:900-908.
7. Conlan MG, Haire WD, Kessinger A, Armitage JO. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991;7:235-240.
8. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990;112:423-428.
9. Boraks P, Seale J, Price J, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998;101:483-486.
10. Masci G, Magagnoli M, Zucali PA, et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-fluorouracil-based chemotherapy? J Clin Oncol 2003;21:736-739.
11. Magagnoli M, Masci G, Carnaghi C, et al. Minidose warfarin is associated with high incidence of international normalized ratio (INR) elevation during chemotherapy with FOLFOX regimen. Ann Oncol 2003;14:959-960.
12. Sletnes KE, Holte H, Halvorsen S. et al. Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman catheter in ABMT patients with malignant lymphoma. Bone Marrow Transplant 1996;17:577-581.
13. van Rooden CJ, Rosendaal FR, Barge RM, et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 2003;123:507-512.
14. Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 2002;118:267-270.
15. Kaufman PA, Jones RB, Greenberg CS, Peters WP. Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury. Cancer 1990;66:515-521.
16. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998;114:207-213.
17. Lagro SW, Verdonck LF, Borel Rinkes IH, Dekker AW. No effect of nodroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 2000;26:1103-1106.
18. Massicotte P, Julian JA, Gent M, et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003;25:101-108.